• Explore /
  • Poster
  • / Perioperative immunochemotherapy (mDCF + avelumab) in locally advanced gastro-esophageal adenocarcinoma: A phase II trial.

Perioperative immunochemotherapy (mDCF + avelumab) in locally advanced gastro-esophageal adenocarcinoma: A phase II trial.

Abstract Poster

Authors

null

Thierry Alcindor

McGill University Health Center, Montréal, QC, Canada

Thierry Alcindor , Pierre-Olivier Fiset , Touhid Opu , Mehrnoush Dehghani , Nicholas Bertos , Carmen L. Mueller , Jonathan Cools-Lartigue , Marc Hickeson , Victoria Marcus , Sophie Camilleri-Broët , Alan Spatz , Gertruda Evaristo , Mina Farag , Giovanni Artho , Arielle Elkrief , Ramy Saleh , Veena Sangwan , Lorenzo Ferri

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer - Local-Regional Disease

Clinical Trial Registration Number

NCT03288350

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4055)

DOI

10.1200/JCO.2023.41.16_suppl.4055

Abstract #

4055

Poster Bd #

376

Abstract Disclosures

Similar Posters

First Author: Thierry Alcindor

First Author: Hongli Li

First Author: MARIA ALSINA

First Author: Claudia Pauligk